Literature DB >> 20824003

Practical Management Recommendations for Anti-ErbB2 Therapy with Lapatinib.

Dimitrios Chatsiproios1, Renate Haidinger, Thomas Suter.   

Abstract

Entities:  

Year:  2008        PMID： 20824003      PMCID： PMC2930991          DOI： 10.1159/000119748

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN： 1661-3791            Impact factor:   2.860


× No keyword cloud information.
  17 in total

Review 1.  Stress pathways and heart failure.

Authors:  K R Chien
Journal:  Cell       Date:  1999-09-03       Impact factor: 41.582

2.  Neuregulin-1/erbB-activation improves cardiac function and survival in models of ischemic, dilated, and viral cardiomyopathy.

Authors:  Xifu Liu; Xinhua Gu; Zhaoming Li; Xinyan Li; Hui Li; Jianjie Chang; Ping Chen; Jing Jin; Bing Xi; Denghong Chen; Donna Lai; Robert M Graham; Mingdong Zhou
Journal:  J Am Coll Cardiol       Date:  2006-09-14       Impact factor: 24.094

Review 3.  Mechanisms of cutaneous toxicities to EGFR inhibitors.

Authors:  Mario E Lacouture
Journal:  Nat Rev Cancer       Date:  2006-10       Impact factor: 60.716

4.  Neuregulin-1 beta attenuates doxorubicin-induced alterations of excitation-contraction coupling and reduces oxidative stress in adult rat cardiomyocytes.

Authors:  Francesco Timolati; Daniel Ott; Laura Pentassuglia; Marie-Noëlle Giraud; Jean-Claude Perriard; Thomas M Suter; Christian Zuppinger
Journal:  J Mol Cell Cardiol       Date:  2006-09-26       Impact factor: 5.000

5.  Cardiac dysfunction in the trastuzumab clinical trials experience.

Authors:  Andrew Seidman; Clifford Hudis; Mary Kathryn Pierri; Steven Shak; Virginia Paton; Mark Ashby; Maureen Murphy; Stanford J Stewart; Deborah Keefe
Journal:  J Clin Oncol       Date:  2002-03-01       Impact factor: 44.544

6.  Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

Authors:  Martine J Piccart-Gebhart; Marion Procter; Brian Leyland-Jones; Aron Goldhirsch; Michael Untch; Ian Smith; Luca Gianni; Jose Baselga; Richard Bell; Christian Jackisch; David Cameron; Mitch Dowsett; Carlos H Barrios; Günther Steger; Chiun-Shen Huang; Michael Andersson; Moshe Inbar; Mikhail Lichinitser; István Láng; Ulrike Nitz; Hiroji Iwata; Christoph Thomssen; Caroline Lohrisch; Thomas M Suter; Josef Rüschoff; Tamás Suto; Victoria Greatorex; Carol Ward; Carolyn Straehle; Eleanor McFadden; M Stella Dolci; Richard D Gelber
Journal:  N Engl J Med       Date:  2005-10-20       Impact factor: 91.245

7.  Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.

Authors:  Edward H Romond; Edith A Perez; John Bryant; Vera J Suman; Charles E Geyer; Nancy E Davidson; Elizabeth Tan-Chiu; Silvana Martino; Soonmyung Paik; Peter A Kaufman; Sandra M Swain; Thomas M Pisansky; Louis Fehrenbacher; Leila A Kutteh; Victor G Vogel; Daniel W Visscher; Greg Yothers; Robert B Jenkins; Ann M Brown; Shaker R Dakhil; Eleftherios P Mamounas; Wilma L Lingle; Pamela M Klein; James N Ingle; Norman Wolmark
Journal:  N Engl J Med       Date:  2005-10-20       Impact factor: 91.245

8.  Recommended guidelines for the treatment of cancer treatment-induced diarrhea.

Authors:  Al B Benson; Jaffer A Ajani; Robert B Catalano; Constance Engelking; Steven M Kornblau; James A Martenson; Richard McCallum; Edith P Mitchell; Thomas M O'Dorisio; Everett E Vokes; Scott Wadler
Journal:  J Clin Oncol       Date:  2004-07-15       Impact factor: 44.544

Review 9.  Pathophysiology and diagnosis of cancer drug induced cardiomyopathy.

Authors:  Christian Zuppinger; Francesco Timolati; Thomas M Suter
Journal:  Cardiovasc Toxicol       Date:  2007       Impact factor: 3.231

Review 10.  Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine.

Authors:  Seppo Ylä-Herttuala; Tuomas T Rissanen; Ismo Vajanto; Juha Hartikainen
Journal:  J Am Coll Cardiol       Date:  2007-02-23       Impact factor: 24.094
View more
  1 in total

1.  Oestrogen enhances cardiotoxicity induced by Sunitinib by regulation of drug transport and metabolism.

Authors:  Pamela Ann Harvey; Leslie Anne Leinwand
Journal:  Cardiovasc Res       Date:  2015-05-25       Impact factor: 10.787
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.